New Delhi, Jan 29 (PTI) India’s pharmaceutical industry is shifting from a volume-driven to a value-driven approach, with greater emphasis on complex generics, biosimilars, and innovation, to move up ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results